NASDAQ · INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL · MID CAP
Mesa Laboratories, Inc. MLAB
16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$249.1M
▲ 3.4% vs FY2024
EPS · FY25
$1.21
Dividend / sh · FY25
$0.64
Payout · FY25
52%
ROE · FY25
3.9%
Net margin · FY25
2.7%
Dividend coverage
1.9×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 249.1M
Revenue, FY2025 · full 16-year series below
Revenue
Net income
3 cents of every revenue dollar became profit this year.
Per share
USD 1.21
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 1.9 times — the rest stayed in the company.
Profitability
3.9%
Return on equity, FY2025
ROE
Operating margin7.4%
Net margin2.7%
Return on assets1.6%
Each USD of equity produced 4 cents of profit this year.
Returned to shareholders
USD 3.5M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 3.5M
Net buybacks—
Share of profit52.5%
Consecutive raises—
USD 3.5M in dividends — 52% of the year's profit went back to shareholders.
Growth
+13.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+4.4%
+13.2%
+11.4%
+14.1%
Net income
+93.3%
+15.4%
−5.0%
+0.5%
EPS, diluted
+92.4%
+13.6%
−8.6%
−2.8%
Dividend / share
+0.0%
+0.0%
Returned to shareholders
+1.1%
+2.2%
+4.3%
+5.9%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years+7.5%
Change, 10 years+51.9%
The share count grew 7% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 427.7M
total assets, end of FY2025
Total assetsUSD 427.7M
EquityUSD 186.2M
CashUSD 26.9M
Gross debtUSD 67.5M
Net debtUSD 40.6M
Current ratio1.72×
Net debt stands at 22% of equity.
History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
Operating income $B
0.0
0.0
−0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
0.0
0.0
−0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
0.0
−0.0
−0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.0
−0.0
−0.3
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
1.21
−0.36
−47.20
0.17
0.35
0.64
0.41
1.86
−0.79
2.91
2.97
2.63
2.49
2.35
2.29
1.86
Dividend / sh $
0.64
0.64
0.64
0.64
0.64
0.64
0.64
0.64
·
·
·
·
·
·
·
·
Payout %
52
−176
−1
366
178
97
153
33
−81
21
21
23
22
21
21
24
ROE %
3.9
−1.3
−94.4
0.2
0.5
1.0
1.1
7.1
−3.0
12.3
14.1
13.9
15.4
17.5
19.7
17.0
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
64 of 64
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed